ITMCTR2100004444招募中1 期
Based on Androgen Receptor Gene to Study the Mechanism of Spleen Deficiency Damp-Heat Syndrome Depression with Seborrheic Alopecia
Tongde Hospital of Zhejiang Province0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Basic Science
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •1. Comply with the diagnostic criteria for depressive episodes in the United States Diagnostic Statistical Methods for Mental Disorders (DSM-V);
- •2. Comply with the diagnostic criteria for seborrheic alopecia in Chinese Clinical Dermatology;
- •3. Comply with the TCM syndrome type of spleen deficiency and damp-heat Type;
- •4. Hamilton Depression Rating Scale (HAMD-17) score >= 17 points;
- •5. Aged 18-65 years (including people aged 18 and 65), gender, culture, economy, etc. are not limited;
- •6. The patient has a clear consciousness, and can cooperate with relevant treatment, testing and inspection, voluntarily sign an informed consent form and be able to comply with the research plan;
- •7. Have not taken disease-related drugs in the past week.
排除标准
- •1. Those with serious self-harm and suicidal tendencies;
- •2. Women who are breastfeeding, pregnant or may become pregnant during the study period;
- •3. Have serious heart, liver, kidney, blood, tumor, immunity, epilepsy and other major diseases, have other mental diseases, have brain organic diseases, and have serious History of dependence on tobacco, alcohol and other psychoactive drugs;
- •4. Other types of hair loss: such as hypothyroidism or hyperthyroidism, hypoparathyroid or pituitary hypofunction, hypogonadism and other endocrine alopecia.
研究者
相似试验
尚未招募
不适用
Detection of aberrant androgen receptor transcripts in circulating tumour cells as a predictor of resistance to AR- directed treatment in patients with castration-resistant prostate cancer.NL-OMON42793niversiteit Antwerpen15
进行中（未招募）
1 期
Dynamics of Androgen Receptor.MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036920Term: Prostate cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036912Term: Prostate cancer stage 0System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036917Term: Prostate cancer stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036919Term: Prostate cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036918Term: Prostate cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate cancerEUCTR2014-000476-26-NLetherlands Cancer Institute50
尚未招募
2 期
Dynamics of Androgen Receptor genomics and transcriptomics after neoadjuvant androgen ablation (DARANA)prostate cancerprostate carcinoma10038597NL-OMON40287Antoni van Leeuwenhoek Ziekenhuis60
Unknown
不适用
Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate CancerProstatic NeoplasmsNCT03677414Medical University of Graz59
尚未招募
不适用
A pilot study to investigate the role of androgens in the sexual functioning of women with primary ovary insufficiency (POI).NL-OMON28298AMC, Amsterdam10